Bayer comments on Monsanto's rejection of improved offer
Bayer reaffirmed that its offer would not be subject to a financing condition. In addition, Bayer has offered a USD 1.5 billion reverse antitrust break fee, reaffirming its confidence in a successful closing.
Bayer is looking forward to continued dialogue with Monsanto under an appropriate confidentiality agreement allowing access to additional information.
For more information:
www.advancingtogether.com